LicianPro

Century Therapeutics, Inc. ·

IPSC 8-K 2026-10-02

Century Therapeutics, Inc. (IPSC) 8-K dated 2026-10-02 — accession 0001104659-26-113055.

Century Therapeutics, Inc. (IPSC) is a biotechnology company listed on US.

Century Therapeutics, Inc. filed a 8-K on 2026-10-02. Accession 0001104659-26-113055.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was -$34.4M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.

Not investment advice. The IPSC SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr